What actually happens in the two weeks after a filler treatment, and when is a touch up appropriate?

In the two weeks after a hyaluronic acid filler treatment, three separate things are happening at once and they resolve on different clocks. Injection edema builds over the first day or two and then recedes. Bruising appears, darkens, turns yellow and clears. And the product itself sits down into the tissue plane, drawing water and softening at its edges as the surrounding tissue stops reacting to having been disturbed.

Two weeks is the standard review point because it is roughly the earliest date at which all three of those processes are far enough along that what you are looking at is the result rather than the recovery. Touch up before that and you are correcting swelling. Correcting swelling means adding product to a face that is about to get smaller, which is how a patient ends up overfilled by an injector who was trying to be responsive.

The exception, and it is the only real one, is a complication. Nothing about the two week rule applies to a suspected vascular event. That is same day, every time.

Day zero to day three: edema, bruising and patient anxiety

The first seventy two hours belong to inflammation. Needle and cannula passes cause tissue trauma, the tissue responds with edema, and hyaluronic acid is hydrophilic, so it pulls water in as well. The lip is the most dramatic because the tissue is loose and highly vascular. A lip that looks alarming on the morning after can be entirely ordinary.

Bruising follows its own course. It typically shows up within the first day, deepens for a couple of days, then shifts through the usual color sequence as the hemoglobin breaks down. Bruises in the tear trough and around the lip tend to linger longest because the tissue is thin and gravity works against clearance.

What matters clinically in this window is telling the patient in advance that this is what will happen. An anxious patient at day two is almost always a patient who was not warned at day zero. Give her the timeline in writing before she leaves, including the sentence that day two often looks worse than day one, and you will remove most of the panic calls.

What matters medically is asymmetric findings. Swelling that is markedly one sided, pain that is worsening rather than easing, or skin color that looks wrong rather than bruised is not the normal course and does not wait.

Keep reading: What does it really cost to open a single room injectable practice in the United States?

Day four to day ten: settling, migration questions and palpable lumps

By the end of the first week the obvious swelling is largely gone and the patient starts examining the result closely. This is when the texture questions arrive.

Palpable firmness at this stage is common and usually not pathological. Product that has been placed as a bolus has not yet been shaped by the surrounding tissue, and edema that has partly resolved can leave the product feeling more distinct than it did on day one. A firm area that is smooth, non tender, not discolored and not visible at rest is generally something to review at two weeks rather than treat now.

Distinguish that from findings that deserve attention sooner.

• A visible ridge or overcorrection at rest, particularly superficial placement in the tear trough or the vermilion border. Sometimes this is genuine placement rather than swelling.
• A tender, warm, expanding nodule. Warmth and tenderness raise the question of infection and change the pathway entirely.
• A firm area appearing weeks or months later, which is a different conversation from a lump at day six and is not a touch up matter.

Migration questions in this window are usually premature. Product moving beyond the vermilion border is a real phenomenon, but at day seven you cannot reliably separate it from residual edema in loose perioral tissue. Say that plainly, book the two week review, and reassess with the swelling gone.

The two week mark and why it is the standard review point

Two weeks is a practical consensus rather than a biological switch. It is the point at which post procedural edema has typically resolved, most bruising has cleared, and hyaluronic acid product has integrated enough that what you palpate and photograph is stable.

The review visit should do four things, in this order.

1. Reshoot the standard photo set under the same conditions as the baseline, before any discussion. Opinions form fast and photographs taken after a conversation get framed to support it.
2. Assess at rest and in animation, both sides, seated and upright. Supine assessment misrepresents volume in the midface.
3. Palpate systematically and note anything firm, its location, its size and whether it is tender or visible.
4. Then ask the patient what she thinks. Her concern may not be the thing you were about to correct.

If a touch up is appropriate, it is usually small. Volume added at the two week visit is refinement, not a second treatment. If you find yourself planning to add as much again as you placed originally, the honest conclusion is that the original plan underdosed the indication, and that is worth saying out loud rather than absorbing quietly.

When two weeks is not the right interval

Collagen stimulating products behave differently from hyaluronic acid. Their result develops over a longer period as the tissue response builds, so a two week review is a safety and satisfaction check rather than a final assessment, and the meaningful review point sits further out. Set that expectation at the time of treatment so the patient is not measuring a stimulator against a filler timeline.

Keep reading: How did one clinic cut its charting time to under five minutes without losing any detail?

What warrants a same day callback instead of waiting

Give the patient a short, specific list. Vague instructions to call if anything seems wrong produce either no calls or all the calls.

Finding	Timing	Action
Pain that is increasing after the first day, or pain out of proportion to the treatment	Immediate	Same day in person assessment
Skin that is white, dusky, gray, or shows a mottled net like pattern	Immediate	Treat as vascular compromise until proven otherwise
Any change in vision, ocular pain, drooping or new neurological symptom	Immediate	Emergency care, do not manage in clinic
Fever, spreading redness, warmth, or purulent discharge	Same day	Assess for infection, consider antibiotics
Blistering, crusting or a developing sore	Same day	Urgent assessment
Firm but painless lump, no discoloration	Routine	Review at the two week visit
Asymmetry noticed at day five	Routine	Reassure, review at two weeks

Put this table on the aftercare sheet with a phone number that reaches a human, and be explicit that the top three rows do not wait for office hours.

Vascular occlusion red flags and the hyaluronidase decision

Intravascular injection or vessel compression is the complication that defines your protocol. The classic presentation is immediate blanching with disproportionate pain, followed by a dusky, mottled discoloration in the distribution of the affected vessel and sluggish capillary refill. Onset can be at the chair or hours later, which is exactly why aftercare instructions matter as much as technique.

For hyaluronic acid products, the treatment is prompt, generous hyaluronidase flooding of the affected territory, repeated as needed, alongside supportive measures and escalation. The decision rule is not complicated: if you are meaningfully considering occlusion, you treat. Hyaluronidase given to a patient who turned out to have only a bad bruise costs you some product and some correction. Hyaluronidase withheld for six hours from a patient who did have an occlusion can cost her tissue.

Practical readiness, which you either have or you do not on the day it happens.

• Hyaluronidase in date, on site, with the quantity you would actually need rather than a single token vial.
• A written protocol every injector has read, not a memory of a training course.
• Documented knowledge of any patient allergy history relevant to hyaluronidase.
• A clear escalation path and the name of the ophthalmology or emergency service you would send someone to.
• Reachability after hours, because occlusion does not respect your closing time.

Note that hyaluronidase does not dissolve non hyaluronic acid products. Your management pathway differs by product, which is one more reason the product and lot belong in the record rather than in someone's recollection.

See how InjectConsent handles this for medical aesthetics and injectables

Scripting the recall so patients actually return

The two week review only protects you if the patient shows up. Most no shows are not reluctance. They are a booking that was never made because the patient was told to call when she was ready.

Book it before she leaves the room, on the same day, at a fixed slot length. Then send two reminders, one at day seven and one the day before. Frame the visit as part of the treatment rather than an optional extra, and say what it is for: to photograph the settled result, check the areas treated, and make any small refinement.

Say the word included if it is included. Ambiguity about whether the review costs money is the single most reliable way to lose the appointment.

Documenting the follow up visit and any correction

The follow up note is a clinical record, not a courtesy. It should carry the date, the interval from treatment, the photographs taken at that visit, the findings on inspection and palpation, the patient's own reported concern in her words, the decision made, and the reasoning behind it. If you added product, record the product, the lot number, the volume and the sites, exactly as you would for an initial treatment. If you declined to add product, record why.

That last line is the one people skip and the one that matters most later. A note saying that firmness at the left tear trough was assessed, judged to be residual edema, and scheduled for reassessment in four weeks is a defense. A blank chart is not.

Building the window into the workflow

None of this requires a new clinical philosophy. It requires that the treatment record, the product lot, the photographs and the two week appointment all get created in the same few minutes, at the chair, while the patient is still in front of you.

That is exactly what InjectConsent is for: signed consent, product lot capture, mapped injection sites and an automatic two week touch up recall, recorded alongside the before photo in the time it takes to clean up. Set the recall as a default rather than a decision, and the two week window stops being a rule you enforce and becomes the way your treatments simply run.